𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Demyelination during anti-tumor necrosis factor α therapy with infliximab for Crohn's disease

✍ Scribed by Carlton W. Thomas Jr.; Brian G. Weinshenker; William J. Sandborn

Book ID
110086152
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
359 KB
Volume
10
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-tumor necrosis factor α: Crohn's di
Anti-tumor necrosis factor α: Crohn's disease guided missile
✍ Alain Bitton 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

## I 73 has been reported to recur after liver transplantation (Hepatology 1993;18:1392). The authors of the current study state that based on the results of their study, they "would not recommend empirical therapy with ursodiol for patients with primary sclerosing cholangitis." The results of th

Antiangiogenic effects of anti–tumor nec
Antiangiogenic effects of anti–tumor necrosis factor α therapy with infliximab in psoriatic arthritis
✍ Juan D. Cañete; José L. Pablos; Raimon Sanmartí; Carmen Mallofré; Sara Marsal; J 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views

## Abstract ## Objective Neovascularization, with an increased number of synovial vessels with a characteristic morphology, seems to contribute to the progression of psoriatic arthritis (PsA). Accordingly, angiogenesis may be an important therapeutic target in PsA. The aim of this study was to ana